PBYI Historical PE Ratio image   This PBYI PE ratio history page last updated 5/9/2022
PBYI Historical PE Ratio Chart
Data adjusted for PBYI split history

PeriodPriceAdj. EPSAnnualizedPE
Q1 2022
5/5/2022
2.24-0.01-0.04NA
Q4 2021
3/3/2022
2.330.210.842.8
Q3 2021
11/4/2021
6.39-0.99-3.96NA
Q2 2021
8/5/2021
6.99-0.13-0.52NA
Q1 2021
5/6/2021
9.680.552.204.4
Q4 2020
2/25/2021
10.55-0.14-0.56NA
Q3 2020
11/5/2020
8.47-0.60-2.40NA
Q2 2020
8/6/2020
10.380.351.407.4
Q1 2020
5/7/2020
9.88-0.43-1.72NA
Q4 2019
2/20/2020
13.96-0.29-1.16NA
Q3 2019
11/6/2019
7.13-0.44-1.76NA
Q2 2019
8/8/2019
9.21-0.97-3.88NA
Q1 2019
5/9/2019
30.02-0.26-1.04NA
Q4 2018
2/28/2019
27.81-0.80-3.20NA
Q3 2018
11/1/2018
38.60-0.37-1.48NA
Q2 2018
8/9/2018
48.65-1.17-4.68NA
Q1 2018
5/9/2018
65.30-0.65-2.60NA
Q4 2017
3/1/2018
61.75-1.03-4.12NA
Q3 2017
11/9/2017
127.20-1.36-5.44NA
Q2 2017
8/9/2017
79.50-1.38-5.52NA
Q1 2017
5/10/2017
30.65-1.16-4.64NA
Q4 2016
3/1/2017
38.05-1.22-4.88NA
Q3 2016
11/9/2016
46.85-1.11-4.44NA
Q2 2016
8/9/2016
46.59-1.17-4.68NA
Q1 2016
5/10/2016
21.87-1.28-5.12NA
Q4 2015
2/29/2016
44.78-1.90-7.60NA
Q3 2015
11/9/2015
90.94-1.10-4.40NA
Q2 2015
8/10/2015
91.65-2.01-8.04NA
Q1 2015
5/11/2015
200.98-1.02-4.08NA
Q4 2014
3/2/2015
213.75-1.03-4.12NA
Q3 2014
11/10/2014
244.79-0.84-3.36NA
Q2 2014
8/11/2014
243.33-1.05-4.20NA
Q1 2014
5/12/2014
72.77-0.50-2.00NA
Q4 2013
3/3/2014
114.02-0.56-2.24NA
Q3 2013
11/12/2013
36.16-0.43-1.72NA
Q2 2013
8/6/2013
55.91-0.44-1.76NA
Q1 2013
5/9/2013
28.61-0.36-1.44NA
Q4 2012
4/1/2013
31.83-0.25-1.00NA
PBYI PE History Chart
PeriodPriceAdj. EPSTTMPE
Q1 2022
5/5/2022
2.24-0.01-0.92NA
Q4 2021
3/3/2022
2.330.21-0.36NA
Q3 2021
11/4/2021
6.39-0.99-0.71NA
Q2 2021
8/5/2021
6.99-0.13-0.32NA
Q1 2021
5/6/2021
9.680.550.1660.5
Q4 2020
2/25/2021
10.55-0.14-0.82NA
Q3 2020
11/5/2020
8.47-0.60-0.97NA
Q2 2020
8/6/2020
10.380.35-0.81NA
Q1 2020
5/7/2020
9.88-0.43-2.13NA
Q4 2019
2/20/2020
13.96-0.29-1.96NA
Q3 2019
11/6/2019
7.13-0.44-2.47NA
Q2 2019
8/8/2019
9.21-0.97-2.40NA
Q1 2019
5/9/2019
30.02-0.26-2.60NA
Q4 2018
2/28/2019
27.81-0.80-2.99NA
Q3 2018
11/1/2018
38.60-0.37-3.22NA
Q2 2018
8/9/2018
48.65-1.17-4.21NA
Q1 2018
5/9/2018
65.30-0.65-4.42NA
Q4 2017
3/1/2018
61.75-1.03-4.93NA
Q3 2017
11/9/2017
127.20-1.36-5.12NA
Q2 2017
8/9/2017
79.50-1.38-4.87NA
Q1 2017
5/10/2017
30.65-1.16-4.66NA
Q4 2016
3/1/2017
38.05-1.22-4.78NA
Q3 2016
11/9/2016
46.85-1.11-5.46NA
Q2 2016
8/9/2016
46.59-1.17-5.45NA
Q1 2016
5/10/2016
21.87-1.28-6.29NA
Q4 2015
2/29/2016
44.78-1.90-6.03NA
Q3 2015
11/9/2015
90.94-1.10-5.16NA
Q2 2015
8/10/2015
91.65-2.01-4.90NA
Q1 2015
5/11/2015
200.98-1.02-3.94NA
Q4 2014
3/2/2015
213.75-1.03-3.42NA
Q3 2014
11/10/2014
244.79-0.84-2.95NA
Q2 2014
8/11/2014
243.33-1.05-2.54NA
Q1 2014
5/12/2014
72.77-0.50-1.93NA
Q4 2013
3/3/2014
114.02-0.56-1.79NA
Q3 2013
11/12/2013
36.16-0.43-1.48NA
Q2 2013
8/6/2013
55.91-0.44NANA
Q1 2013
5/9/2013
28.61-0.36NANA
Q4 2012
4/1/2013
31.83-0.25NANA
Quotes delayed 20 minutes

Email EnvelopeFree PBYI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Puma Biotechnology (PBYI) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

PCRX PE Ratio History
PCSA PE Ratio History
PCVX PE Ratio History
PDCO PE Ratio History
PDEX PE Ratio History
PDSB PE Ratio History
PEN PE Ratio History
PETV PE Ratio History
PFE PE Ratio History
PGEN PE Ratio History
How should the PBYI historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Puma Biotechnology. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this PBYI Historical PE Ratio page.

What is the average historical PE for PBYI based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The PBYI historical PE ratio using the annualized quarterly earnings method works out to 4.9.

What is the average historical PE for PBYI based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The PBYI historical PE ratio using the TTM earnings method works out to 60.5.

On this page we presented the PBYI Historical PE Ratio information for Puma Biotechnology' stock. The average PBYI historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 4.9. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PBYI historical PE based on this TTM earnings result method is 60.5. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PBYI historical PE result, against the recent PE: when this page was posted on 5/6/2022, the most recent closing price for PBYI had been 1.99, and the most recent quarterly earnings result, annualized, was 0.84. Meanwhile, the most recent TTM earnings summed to 0.16. From these numbers, we calculate the recent PBYI PE on 5/6/2022 based on annualized quarterly EPS was 2.4. Based on PBYI's history, that recent PE is low relative to the historical average, with the recent PE 51.0% lower than the historical average PE across our data set for Puma Biotechnology. Looking at the recent PBYI PE on 5/6/2022 based on TTM EPS, we calculate the ratio at 12.4. Based on PBYI's history, that recent PE is low relative to the historical average, with the recent PE 79.5% lower than the average PE across our Puma Biotechnology data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on PBYI or any other given stock, valuation analysis for PBYI can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Puma Biotechnology PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PBYI. Thanks for visiting, and the next time you need to research PBYI Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: PSN YTD Return, INVA Videos, ROL Options Chain.

 

PBYI Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.